Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 202-870-9 | CAS number: 100-61-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / bone marrow chromosome aberration
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Comparable to guideline study with acceptable restrictions Read-across is based on the great structural similarity between aniline and N-methylaniline
Data source
Reference
- Reference Type:
- publication
- Title:
- Unnamed
- Year:
- 1 991
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 475 (Mammalian Bone Marrow Chromosome Aberration Test)
- Deviations:
- not applicable
- Principles of method if other than guideline:
- In order to investigate whether the species specific carcinogenicity is reflected in the results of the bone marrow micronucleus tests after oral dosing, aniline hydrochloride was assayed for potential clastogenicity in the mouse micronucleus test after oral administration to male CRH mice. A group of animals dosed i.p. with aniline hydrochloride was included for comparative purposes.
- GLP compliance:
- not specified
- Type of assay:
- micronucleus assay
Test material
- Reference substance name:
- Aniline hydrochloride
- IUPAC Name:
- Aniline hydrochloride
- Reference substance name:
- Anilinium chloride
- EC Number:
- 205-519-8
- EC Name:
- Anilinium chloride
- Cas Number:
- 142-04-1
- IUPAC Name:
- anilinium chloride
- Details on test material:
- - Name of test material (as cited in study report): Aniline hydrochloride
- Analytical purity: > 99%
Constituent 1
Constituent 2
Test animals
- Species:
- mouse
- Strain:
- other: CRH
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Rodent Breeding Unit, Glaxo Group Research Ltd
- Age at study initiation: 7-8 wks old
- Diet (e.g. ad libitum): no.l Special Diets Services diet
- Water (e.g. ad libitum): ad libitum
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- - Vehicle(s)/solvent(s) used: [sterile water]
- Duration of treatment / exposure:
- 24 or 48 hr
- Frequency of treatment:
- Single dose
- Post exposure period:
- None
Doses / concentrationsopen allclose all
- Remarks:
- Doses / Concentrations:
380 mg/kg
Basis:
nominal conc.
i.p. route
- Remarks:
- Doses / Concentrations:
400, 500 and 1000 mg/kg
Basis:
nominal conc.
oral route
- No. of animals per sex per dose:
- 4 to 8 animals/group
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- cyclophosphamide
- Route of administration: oral
Examinations
- Tissues and cell types examined:
- Polychromatic erythrocytes
- Details of tissue and slide preparation:
- DETAILS OF SLIDE PREPARATION: Slides were coded prior to analysis and stained using the May-Grunwald/Giemsa technique. Some additional slides were also stained using a Feulgen-Iight green staining technique for DNA
METHOD OF ANALYSIS: For each animal, 2000 polychromatic erythrocytes (PE) were analysed for the presence of micronuclei. Five hundred erythrocytes/animal were scored to determine the percentage of PE among all erythrocytes. - Statistics:
- The likelihood ratio test was used to analyse the data from the two i.p. dosing experiments. For the oral dosing experiments statistical analyses of micronucleus frequencies were performed using the non-parametric Dunn's multiple comparison test, with the exception of the repeat test where the Wilcoxon two-sample test was employed due to the use of only one dose group.
Results and discussion
Test results
- Sex:
- male
- Genotoxicity:
- positive
- Toxicity:
- no effects
- Vehicle controls validity:
- valid
- Negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- Aniline was positive in the standard (single dose) mouse bone marrow micronucleus test, 24 h after oral dosing, but only at the high dose level of 1000 mg/kg
Any other information on results incl. tables
Table 1. Results of micronucleus test in CRH mice with a single dose of aniline
Treatment | Dose (mg/kg) | Sex | Sample time (h) | No. of animals | MNPE/1000 PE individual animal values | MNPE/1000PE (mean ± SD) | PE(%)(± SD) |
Oral dosing (first study) | |||||||
Water | 10 ml/kg | M | 24 | 7 | 1,0.5,0,0.5,0,0.5,0.5 | 04 ± 0.3 | 44 ± 8 |
Aniline* | 4005001000 | M | 242424 | 778 | 2,1.5,0,1,3,0,00.5,2.5,1,2,0,1,218.5,15,4.5,3,2.5,2.5,4,12 | 1.1 ± 1.21.3 ± 0.96.1 ± 6.b | 37 ± 530 ± 849 ± 17 |
Cyclophosphamide | 30 | M | 24 | 4 | 9,11,18,6.5 | 11.1 ± 4.9c | 57 ± 15 |
Water | 10 ml/kg | M | 48 | 7 | 0,0,1,0.5,2,0,0 | 0.5 ± 0.8 | 49 ± 12 |
Aniline* | 4005001000 | M | 484848 | 777 | 1,0,1,0.5,0,0.5,0.50.5,0,0.5,0,0,0,1.51,0,1,1,1,1,2 | 0.5 ± 0.40.4 ± 0.61.0 ± 0.6 | 50 ± 849 ± 1039 ± 7 |
Oral dosing (repeat study) | |||||||
Water | 10 ml/kg | M | 24 | 7 | 0,1.5,0.5,0,1,0.5,1.5 | 0.7 ± 0.6 | 42 ± 6 |
Aniline* | 1000 | M | 24 | 7 | 3,2.5,2,6,10,15,0.5 | 5 6 ± 5.2b | 38 ± 6 |
Cyclophosphamide | 30 | M | 24 | 2 | 8,6.5 | 7.3c | 43 |
I.p. dosing (first study) | |||||||
0.9% NaCl | 5 ml/kg | M | 24 | 4 | 0,0.5,0.5,0 | 0.3 ± 0.3 | 42 ± 14 |
Aniline* | 380 | M | 24 | 4 | 1,4 5,3.5,3.5 | 3.1 ± 1.5b | 36 ± 8 |
I.p. dosing (repeat study) | |||||||
0.9% NaCl | 5 ml/kg | M | 24 | 8 | 0.5,0,0,0.5,1,0,1,0.5 | 0.4 ± 0.4 | 37 ± 9 |
Aniline* | 380 | M | 24 | 8 | 2.5,0,1.5,4.5,2.5,3,4.5,2.5 | 2.6 ± 1.5b | 34 ± 12 |
* Dose levels are expressed as mg/kg free base
b Treatment significantly different from control (P < 0.05).
c Positive control is not included in the statistical analyses.
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): positive
The high oral dose of aniline needed for micronucleus induction, the presence of micronuclei with abnormal morphology and the large inter-animal variability found within this group may possibly indicate a more complex mechanism of micronucleus induction than simple clastogenicity.
Given the high resemblance between aniline and N-methylaniline, and their similar physico-chemical properties, the results obtained in this study can be attributed to N-methylaniline.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.